Global Dry Eye Syndrome Drugs Market 2017-2021
SKU ID :TNV-11359290 | Published Date: 24-Oct-2017 | No. of pages: 88Description
About Dry Eye Syndrome Drugs
Dry eye syndrome, also known as keratoconjunctivitis sicca, is the condition of having dry eyes where either the eyes are not capable of producing sufficient tears to maintain lubrication or the when produced, they evaporate too quickly. The condition can lead to various difficulties in the daily life of a person, such as reading for an extended period of time or using a computer. The condition can decrease the tolerance of a person in a dry environment such as air present inside an airplane.
Technavio’s analysts forecast the global dry eye syndrome drugs market to grow at a CAGR of 7.59% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global dry eye syndrome drugs market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Dry Eye Syndrome Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Allergan
• Novartis
• Otsuka Holdings
• Santen Pharmaceutical
Other prominent vendors
• Aerie Pharmaceutical
• Akorn
• Bausch & Lomb
• Johnson & Johnson
• Merck
• MIMETOGEN
• ReGenTree
• Sun Pharmaceutical
• Teva Pharmaceutical
Market driver
• Untapped potential in developing countries
• For a full, detailed list, view our report
Market challenge
• Lack of ophthalmology experts
• For a full, detailed list, view our report
Market trend
• Initiatives and programs for supporting patients with ophthalmic disorders
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Dry eye syndrome, also known as keratoconjunctivitis sicca, is the condition of having dry eyes where either the eyes are not capable of producing sufficient tears to maintain lubrication or the when produced, they evaporate too quickly. The condition can lead to various difficulties in the daily life of a person, such as reading for an extended period of time or using a computer. The condition can decrease the tolerance of a person in a dry environment such as air present inside an airplane.
Technavio’s analysts forecast the global dry eye syndrome drugs market to grow at a CAGR of 7.59% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global dry eye syndrome drugs market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Dry Eye Syndrome Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Allergan
• Novartis
• Otsuka Holdings
• Santen Pharmaceutical
Other prominent vendors
• Aerie Pharmaceutical
• Akorn
• Bausch & Lomb
• Johnson & Johnson
• Merck
• MIMETOGEN
• ReGenTree
• Sun Pharmaceutical
• Teva Pharmaceutical
Market driver
• Untapped potential in developing countries
• For a full, detailed list, view our report
Market challenge
• Lack of ophthalmology experts
• For a full, detailed list, view our report
Market trend
• Initiatives and programs for supporting patients with ophthalmic disorders
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
TOC
Tables & Figures
Companies
- PRICE
-
$2500$4000Buy Now